These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22672008)

  • 1. Terlipressin-induced extensive skin necrosis: a case report and published work review.
    Lu YY; Wei KC; Wu CS
    J Dermatol; 2012 Oct; 39(10):866-8. PubMed ID: 22672008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extensive cutaneous necrosis due to terlipressin use].
    Herrera I; Leiva-Salinas M; Palazón JM; Pascual JC; Niveiro M
    Gastroenterol Hepatol; 2015 Jan; 38(1):12-3. PubMed ID: 24837003
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous necrosis secondary to terlipressin therapy.
    Posada C; Feal C; García-Cruz A; Alvarez V; Alvarez M; Cruces MJ
    Acta Derm Venereol; 2009; 89(4):434-5. PubMed ID: 19688169
    [No Abstract]   [Full Text] [Related]  

  • 4. Extensive epidermal necrosis due to terlipressin.
    Yefet E; Gershovich M; Farber E; Soboh S
    Isr Med Assoc J; 2011 Mar; 13(3):180-1. PubMed ID: 21608341
    [No Abstract]   [Full Text] [Related]  

  • 5. Terlipressin-induced skin necrosis and rhabdomyolysis.
    Zimmer V; Lammert F
    Am J Med Sci; 2010 Dec; 340(6):506. PubMed ID: 20818227
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review.
    Iglesias Julián E; Badía Aranda E; Bernad Cabredo B; Corrales Cruz D; Romero Arauzo MJ
    Rev Esp Enferm Dig; 2017 May; 109(5):380-382. PubMed ID: 28112958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic complications of Glypressin in liver disease: a case series.
    Donnellan F; Cullen G; Hegarty JE; McCormick PA
    Br J Clin Pharmacol; 2007 Oct; 64(4):550-2. PubMed ID: 17880357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear IgA bullous dermatosis due to vancomycin and cutaneous necrosis due to terlipressin in the same patient.
    Castellanos-González M; Marzal-Alfaro MB; Díaz-Sánchez A; Martos MG
    Indian J Dermatol Venereol Leprol; 2016; 82(6):723-726. PubMed ID: 27643543
    [No Abstract]   [Full Text] [Related]  

  • 9. Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin).
    Mégarbané H; Barete S; Khosrotehrani K; Izzedine H; Moguelet P; Chosidow O; Frances C; Aractingi S
    Dermatology; 2009; 218(4):334-7. PubMed ID: 19155616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terlipressin-exacerbated hypokalaemia.
    Stéphan F; Paillard F
    Lancet; 1998 Apr; 351(9111):1249-50. PubMed ID: 9643748
    [No Abstract]   [Full Text] [Related]  

  • 11. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin and tricyclic antidepressant intoxication.
    Zuidema X; de Jager CP
    Neth J Med; 2007 Sep; 65(8):313-4. PubMed ID: 17890795
    [No Abstract]   [Full Text] [Related]  

  • 13. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy.
    Shawcross DL; Davies NA; Mookerjee RP; Hayes PC; Williams R; Lee A; Jalan R
    Hepatology; 2004 Feb; 39(2):471-5. PubMed ID: 14768000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
    García-Compeán D; Blanc P; Bories JM; Michel J; Desprez D; Pageaux GP; David XR; Larrey D; Michel H
    Arch Med Res; 1997; 28(2):241-5. PubMed ID: 9204616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic rhabdomyolysis induced by terlipressin infusion in a uraemic patient suffering from AA-type amyloidosis.
    Rolla D; Cannella G; Ravetti JL
    Nephron; 1999; 83(2):167-8. PubMed ID: 10516498
    [No Abstract]   [Full Text] [Related]  

  • 16. Telipressin induced peripheral ischaemic gangrene and skin necrosis.
    Sahu S; Panda K; Patnaik S; Rath J
    Trop Gastroenterol; 2010; 31(3):229-30. PubMed ID: 21560534
    [No Abstract]   [Full Text] [Related]  

  • 17. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.
    Alessandria C; Ottobrelli A; Debernardi-Venon W; Todros L; Cerenzia MT; Martini S; Balzola F; Morgando A; Rizzetto M; Marzano A
    J Hepatol; 2007 Oct; 47(4):499-505. PubMed ID: 17560680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
    Salluh JI; Martins GA; Santino MS; Araújo LV; Freitas GG; Verdeal JC
    Acta Anaesthesiol Scand; 2007 Apr; 51(4):505-8. PubMed ID: 17378791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome.
    Di Micoli A; Bracci E; Cappa FM; Casadio R; Zambruni A; Fontana K; Bernardi M; Trevisani F
    Dig Liver Dis; 2008 Apr; 40(4):304-5. PubMed ID: 18160353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction.
    Carmo LS; Baima DC; Blefari V; Zonta V; Troncon LE; Rossi MA
    Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):505-511. PubMed ID: 24855284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.